| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
|
Niccolini, Flavia
|
|
2016
|
43 |
12 |
p. 2244-2254
|
article
|
| 2 |
Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
|
Harada, Ryuichi
|
|
2016
|
43 |
12 |
p. 2211-2218
|
article
|
| 3 |
Comments on Van den Wyngaert et al., The EANM practice guidelines for bone scintigraphy
|
Starck, Sven-Åke
|
|
2016
|
43 |
12 |
p. 2263-2264
|
article
|
| 4 |
Comparison between MRI-based attenuation correction methods for brain PET in dementia patients
|
Cabello, Jorge
|
|
2016
|
43 |
12 |
p. 2190-2200
|
article
|
| 5 |
Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
|
Pyka, Thomas
|
|
2016
|
43 |
12 |
p. 2114-2121
|
article
|
| 6 |
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
|
Ahmad, Rawaha
|
|
2016
|
43 |
12 |
p. 2219-2227
|
article
|
| 7 |
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
|
Zegers, Catharina M. L.
|
|
2016
|
43 |
12 |
p. 2139-2146
|
article
|
| 8 |
Feasibility and acceptance of simultaneous amyloid PET/MRI
|
Schütz, Lisa
|
|
2016
|
43 |
12 |
p. 2236-2243
|
article
|
| 9 |
18F-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patients
|
Kim, Jahae
|
|
2016
|
43 |
12 |
p. 2228-2235
|
article
|
| 10 |
Guidelines to PET measurements of the target occupancy in the brain for drug development
|
Takano, Akihiro
|
|
2016
|
43 |
12 |
p. 2255-2262
|
article
|
| 11 |
How reliable is 18FDG PET for predicting the onset of Huntington’s disease?
|
Ciarmiello, Andrea
|
|
2016
|
43 |
12 |
p. 2180-2182
|
article
|
| 12 |
ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer
|
Sun, Haiyan
|
|
2016
|
43 |
12 |
p. 2169-2179
|
article
|
| 13 |
ImmunoPET to help stratify patients for targeted therapies and to improve drug development
|
Kraeber-Bodere, Françoise
|
|
2016
|
43 |
12 |
p. 2166-2168
|
article
|
| 14 |
In memoriam: Prof. Ignac Fogelman (04.09.1948 – 05.07.2016)
|
Gnanasegaran, Gopinath
|
|
2016
|
43 |
12 |
p. 2273-2274
|
article
|
| 15 |
Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain
|
Feeney, Claire
|
|
2016
|
43 |
12 |
p. 2201-2210
|
article
|
| 16 |
Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy
|
Regula, Naresh
|
|
2016
|
43 |
12 |
p. 2131-2138
|
article
|
| 17 |
99mTc-DPD-scintigraphy with intense uptake in fat tissue caused by AL-amyloidosis
|
Zoller, M.
|
|
2016
|
43 |
12 |
p. 2269-2270
|
article
|
| 18 |
Paraneoplastic syndrome demonstrated on 99mTc-HMDP bone scan
|
Lancelot, Sophie
|
|
2016
|
43 |
12 |
p. 2271-2272
|
article
|
| 19 |
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer
|
Ceci, Francesco
|
|
2016
|
43 |
12 |
p. 2103-2104
|
article
|
| 20 |
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer
|
Schwarzenböck, Sarah M.
|
|
2016
|
43 |
12 |
p. 2105-2113
|
article
|
| 21 |
Reply to: Starck et al.
|
Wyngaert, Tim Van den
|
|
2016
|
43 |
12 |
p. 2265-2266
|
article
|
| 22 |
Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET)
|
Kameyama, Masashi
|
|
2016
|
43 |
12 |
p. 2267-2268
|
article
|
| 23 |
Striatal hypometabolism in premanifest and manifest Huntington’s disease patients
|
López-Mora, Diego Alfonso
|
|
2016
|
43 |
12 |
p. 2183-2189
|
article
|
| 24 |
Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand
|
Boschi, Stefano
|
|
2016
|
43 |
12 |
p. 2122-2130
|
article
|
| 25 |
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy
|
Okamoto, Shozo
|
|
2016
|
43 |
12 |
p. 2147-2154
|
article
|
| 26 |
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib
|
Ho, Kung-Chu
|
|
2016
|
43 |
12 |
p. 2155-2165
|
article
|
Journal description